Frontlight ResearchEarly access
Glioblastoma trials in United States
181 of 199 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleHSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Where
- Birmingham, Houston, St Louis
- Age
- 36 months to 22 years
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03911388 - Phase 3Taking peopleSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Where
- Atlanta, Aurora, Billings, Birmingham, Boston, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, Fairfax, Gainesville, Houston, Indianapolis, Jacksonville, Kansas City, La Jolla, Lexington, Los Angeles, Madison, Miami, Minneapolis, Nashville, New Brunswick, New Haven, Newport Beach, New York, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, Salt Lake City, San Antonio, San Francisco, Seattle, St Louis, Winston-Salem
- Age
- 18 years and over
- People
- 365 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT05303519 - Phase 1Taking peopleProspective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
- Where
- Cleveland
- Age
- 18 years and over
- People
- 10
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT05565118 - Phase 1/2Taking peopleA Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Where
- Chicago, Dallas, Houston, New York, Salt Lake City, San Antonio, Seattle
- Age
- 18 years and over
- People
- 116 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT05765812 · EU 2022-502156-31-00 - Phase 2Taking peopleA Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
- Where
- Cleveland
- Age
- 18 years and over
- People
- 48
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT07003542 - Phase 3Taking peopleAdvanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial
- Where
- Albert Lea, Eau Claire, Jacksonville, La Crosse, Mankato, Northfield, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 292
- Run by
- Mayo Clinic
See details and how to joinNCT07935889 - Phase 1/2Taking peopleSuper-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Where
- New York
- Age
- 18 years and over
- People
- 33
- Run by
- Northwell Health
See details and how to joinNCT02861898 - Phase 1/2Taking peopleOral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- Where
- New York
- Age
- 18 years to 74 years
- People
- 67
- Run by
- Northwell Health
See details and how to joinNCT03213002 - Phase 2Taking peopleIdentifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
- Where
- Ann Arbor, Atlanta, Birmingham, Charlotte, Durham, Huntington, Jacksonville, Los Angeles, Madison, Menomonee Falls, Milwaukee, Morgantown, Oak Creek, Providence, Tampa, West Bend, Winston-Salem
- Age
- 18 years and over
- People
- 100
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT06319027 - Phase 1Taking peopleRNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
- Where
- Gainesville, Washington D.C.
- Age
- 4 years to 39 years
- People
- 24
- Run by
- University of Florida
See details and how to joinNCT07492316 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Where
- Columbus, New York, Scottsdale
- Age
- 18 years to 85 years
- People
- 20
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT06910306 - Phase 1/2Taking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Aurora, Birmingham, Boston, Denver, Duarte, Grand Rapids, Irving, Los Angeles, Milwaukee, Nashville, New York, Orlando, San Antonio, San Francisco, Stanford
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - Phase 2Taking peopleStudy of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Where
- Ann Arbor, Atlanta, Baltimore, Birmingham, Boston, Charlotte, Cleveland, Columbus, Detroit, Fairfax, Greenville, Hackensack, Houston, La Jolla, Lake Success, Los Angeles, Madison, Miami, Minneapolis, New Brunswick, New Haven, New York, Omaha, Orange, Palo Alto, Philadelphia, Pittsburgh, Richmond, Salt Lake City, Scarborough, Springdale, St Louis, Summit, Tampa, The Bronx, Washington D.C., Winston-Salem
- Age
- 18 years and over
- People
- 162
- Run by
- Black Diamond Therapeutics, Inc.
See details and how to joinNCT07326566 - No phaseNot yet taking people in United StatesAdaptive Radiotherapy for Patients With GBM
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 20
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07932405 - Phase 1Not yet taking people in United StatesSurgical Window Study of CM93 in Subjects With Recurrent Glioblastoma (rGBM)
- Where
- Boston, New York, Rochester
- Age
- 18 years and over
- People
- 72
- Run by
- NYU Langone Health
See details and how to joinNCT07927491 - Phase 1Not yet taking people in United StatesA Phase I Clinical Study of YN003 in the Treatment of Glioma
- Where
- Houston, Los Angeles, San Francisco
- Age
- 18 years to 70 years
- People
- 50 worldwide
- Run by
- Beijing Inno Medicine Co., Ltd.
See details and how to joinNCT07929909 - Phase 1/2Taking peopleTesting the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Where
- Atlanta, Aurora, Buffalo, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Coral Gables, Deerfield Beach, Duarte, Irvine, Jacksonville, La Jolla, Lexington, Livingston, Los Angeles, Madison, Miami, Newark, New Brunswick, New York, Oklahoma City, Orange, Orland Park, Phoenix, Pittsburgh, Richmond, Rochester, Sacramento, Salt Lake City, Tampa, West Chester, Winston-Salem
- Age
- 18 years and over
- People
- 97
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05432804 - Phase 3Taking peopleBeginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Where
- Atlanta, Baltimore, Charleston, Chicago, Columbia, Columbus, Fairfax, Greenville, Houston, Lebanon, Littleton, Los Angeles, Louisville, Neptune City, Orlando, Pittsburgh, Providence, San Francisco, Scottsdale, Valhalla
- Age
- 18 years and over
- People
- 766
- Run by
- GT Medical Technologies, Inc.
See details and how to joinNCT07195591 - Phase 1/2Not yet taking people in United StatesCombination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
- Where
- San Francisco
- Age
- 3 years to 39 years
- People
- 97
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT07389278 - Phase 2Taking peopleAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Where
- Grand Forks, Jacksonville
- Age
- 18 years and over
- People
- 220
- Run by
- Mayo Clinic
See details and how to joinNCT05969860 - Phase 1/2Taking peoplePLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 146
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06161519 - Phase 1Taking peopleAnti-GD2 ADC M3554 in Advanced Solid Tumors
- Where
- Boston, Houston, New York
- Age
- 18 years and over
- People
- 65 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00 - Phase 1Taking peopleMultiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
- Where
- Chicago, Duarte, Stanford, Winston-Salem
- Age
- 18 years and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT05139056 - Phase 1Taking peopleA Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Where
- Chicago, New York, Palo Alto, Tampa
- Age
- 18 years and over
- People
- 30
- Run by
- Tetragon Biosciences Ltd
See details and how to joinNCT07464925 - No phaseTaking peopleLiving Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
- Where
- Aurora, Cleveland
- Age
- 18 years and over
- People
- 64
- Run by
- University of Colorado, Denver
See details and how to joinNCT07628647